| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 161,309 | 167,735 | 161,925 | 248,496 | | Cost of Revenue | 60,502 | 64,558 | 63,471 | 98,054 | | | Gross Profit | 100,807 | 103,177 | 98,454 | 150,442 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 81,493 | 82,495 | 79,605 | 100,423 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 19,314 | 20,682 | 18,849 | 50,019 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 101 | 92 | 69 | 63 | | Earnings Before Interest And Taxes | 19,415 | 20,774 | 18,918 | 50,082 | | Interest Expense | 93 | 110 | 98 | 90 | | Income Before Tax | 19,322 | 20,664 | 18,820 | 49,992 | | Income Tax Expense | 7,594 | 8,152 | 7,365 | 19,583 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 11,728 | 12,512 | 11,455 | 30,409 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 11,728 | 12,512 | 11,455 | 30,409 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $11,728 | $12,512 | $11,455 | $30,409 |
|
0.14% Nasdaq 
0.539 (1.26%) 
Income Statement
